RLMD · Relmada Therapeutics, Inc.
Market Cap
$475.75M
Shares
106.67M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-07 | 22,503 | $5.37 | $120,841 |
| 2026-08-06 | 10,495 | $5.44 | $57,093 |
| 2026-08-05 | 9,301 | $5.47 | $50,876 |
| 2026-07-28 | 1,684 | $5.20 | $8,757 |
| 2026-07-17 | 984 | $5.46 | $5,373 |
| 2026-07-09 | 32,209 | $6.41 | $206,460 |
| 2026-06-30 | 77,337 | $6.98 | $539,812 |
| 2026-06-29 | 22,774 | $6.69 | $152,358 |
| 2026-06-22 | 571,604 | $6.73 | $3,846,895 |
| 2026-06-18 | 571,804 | $6.60 | $3,773,906 |
| 2026-06-17 | 571,852 | $6.55 | $3,745,631 |
| 2026-06-16 | 131,419 | $6.37 | $837,139 |
| 2026-06-15 | 2,791 | $6.65 | $18,560 |
Showing 1–13 of 13 settlements
Key facts
CIK
1553643
CUSIP
75955J402
13F (30d)
111 filings
110 filers
Visit website
Investor relations